Literature DB >> 20484059

Consulting a trained physician when considering a request for euthanasia: an evaluation of the process in flanders and the Netherlands.

Yanna Van Wesemael1, Joachim Cohen, Johan Bilsen, Bregje D Onwuteaka-Philipsen, Wim Distelmans, Luc Deliens.   

Abstract

In Belgium and the Netherlands, consultation of a second independent physician by the attending physician is mandatory in euthanasia cases. In both countries, specialized consultation services have been established to provide physicians trained for that purpose. This retrospective study describes and compares the quality of consultation of both services based on surveys of attending physicians and those providing the consultation (consultants). While Dutch consultants discussed certain subjects, for example, alternative curative or palliative treatment more often with the attending physician than Belgian consultants, both usually discussed those subjects considered necessary for a quality consultation and were independent from patient and attending physician. Over 90% of attending physicians in both countries evaluated the consultant's knowledge of palliative care, patient's disease, and judicial procedure, and their communication skills, as sufficient. Consultation with specialized consultation services seems to promote quality of euthanasia consultations.

Entities:  

Mesh:

Year:  2010        PMID: 20484059     DOI: 10.1177/0163278710370605

Source DB:  PubMed          Journal:  Eval Health Prof        ISSN: 0163-2787            Impact factor:   2.651


  2 in total

1.  Facilitators and barriers for GP-patient communication in palliative care: a qualitative study among GPs, patients, and end-of-life consultants.

Authors:  Willemjan Slort; Annette H Blankenstein; Luc Deliens; Henriëtte E van der Horst
Journal:  Br J Gen Pract       Date:  2011-04       Impact factor: 5.386

Review 2.  Culture and end of life care: a scoping exercise in seven European countries.

Authors:  Marjolein Gysels; Natalie Evans; Arantza Meñaca; Erin Andrew; Franco Toscani; Sylvia Finetti; H Roeline Pasman; Irene Higginson; Richard Harding; Robert Pool
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.